Abstract:Over the past decade, a surge of evidence has documented various pathological processes in the retina of patients suffering from mild cognitive impairment, Alzheimer's disease (AD), Parkinson's disease (PD), and other neurodegenerative diseases. Numerous studies have shown that the retina, a central nervous system tissue formed as a developmental outgrowth of the brain, is profoundly affected by AD. Harboring the earliest detectable disease-specific signs, amyloid β-protein (Aβ) plaques, the retina of AD patients undergoes substantial ganglion cell degeneration, thinning of the retinal nerve fiber layer, and loss of axonal projections in the optic nerve, among other abnormalities. More recent investigations described Aβ plaques in the retina located within sites of neuronal degeneration and occurring in clusters in the mid- and far-periphery of the superior and inferior quadrants, regions that had been previously overlooked. Diverse structural and/or disease-specific changes were also identified in the retina of PD, Huntington's disease, and multiple sclerosis patients. The pathological relationship between the retina and brain prompted the development of imaging tools designed to noninvasively detect and monitor these signs in living patients. One such tool is optical coherence tomography (OCT), uniquely providing high-resolution two-dimensional cross-sectional imaging and three-dimensional volumetric measurements. As such, OCT emerged as a prominent approach for assessing retinal abnormalities in vivo, and indeed provided multiple parameters that allowed for the distinction between normal aged individuals and patients with neurodegenerative diseases. Beyond the use of retinal optical fundus imaging, which recently allowed for the detection and quantification of amyloid plaques in living AD patients via a wide-field view of the peripheral retina, a major advantage of OCT has been the ability to measure the volumetric changes in specified retinal layers. OCT has proven to be particularly useful in analyzing retinal structural abnormalities consistent with disease pathogenesis. In this review, we provide a summary of OCT findings in the retina of patients with AD and other neurodegenerative diseases. Future studies should explore the combination of imaging early hallmark signs together with structural-functional biomarkers in the accessible retina as a practical means of assessing risk, disease progression, and therapeutic efficacy in these patients.

Neuro-ophthalmic disease and optical coherence tomography: glaucoma look-alikes

Optical coherence tomography of the retina: applications in neurology

Optical coherence tomography (OCT) in neuro-ophthalmology

Macular thickness assessment with optical coherence tomography for glaucoma early diagnosis

[OCT in Neuroophthalmology]

Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration

Optical Coherence Tomography in Measuring Retinal Nerve Fiber Layer Thickness in Normal Subjects and Patients with Open-Angle Glaucoma

Retinal Nerve Fiber Layer in Primary Open-Angle Glaucoma with High Myopia Determined by Optical Coherence Tomography and Scanning Laser Polarimetry.

Discriminating capabilities of neural and vascular parameters of optical coherent tomography in glaucoma

Optical Coherence Tomography Evaluation of Retinal Nerve Fiber Layer Thickness in Non-Arteritic Anterior Ischemic Optic Neuropathy and Primary Open Angle Glaucoma: a Systematic Review and Meta-analysis

Optical Coherence Tomography in Alzheimer’s Disease and Other Neurodegenerative Diseases

Optical Coherence Tomography Angiography Assessment of the Peripapillary Vessel Density and Structure in Patients with Nonarteritic Anterior Ischemic Optic Neuropathy: A Meta-Analysis

The clinical role of optical coherence tomography in monitoring glaucomatous optic neuropathy progression

The Role of Optical Coherence Tomography Angiography in Glaucoma

Focusing on the Application of Optical Coherence Tomography in the Field of Neuro-Ophthalmology

Optic nerve and retinal nerve fiber layer analyzers in glaucoma

Re-evaluating diabetic papillopathy using optical coherence tomography and inner retinal sublayer analysis

Correlation Between Retinal Nerve Fiber Layer and Optic Neuropathy Measured by Optical Coherence Tomography in Primary Open Angle Glaucoma

Current Status and Future Perspectives of Optic Nerve Imaging in Glaucoma

New developments in optical coherence tomography for glaucoma

Retinal changes in Parkinson's disease and glaucoma